Mycoplasma Testing Market: Global Industry Research Report 2020-2028

Mycoplasma Testing Market: COVID-19 Impact and Global Analysis Forecast to 2028

Published Date: May 2021

No. of Pages: 208

Status: Upcoming

Report Code: EMR100086

Mycoplasma contamination affects the cell line growth and characteristics. The contamination may occur through contact with other formerly infected cultures. The mycoplasma can be transmitted by the cell culture technician or through the use of contaminated reagents. The adoption of appropriate handling and testing procedures minimizes the risk of contamination from these sources.Due to rising R&D investments in the field of life sciences, the need and demand for mycoplasma testing products are projected to increase in the coming future. The high opportunities in the life sciences segment are driving the market growth. Hence, large amount of investment is being made in the biotechnology and pharmaceutical industries with hiking level of healthcare spending worldwide. This is estimated to elicit high evolution of mycoplasma testing market.



The numerous factors which are increasing the growth of the market are the speedy growth in the R&D investments, pharmaceutical and biotechnology industries, and government support. Mycoplasma testing is accepted out in the research and production of all biopharmaceutical products. The hike in the biotechnology and pharmaceutical sector across the globe provides as a direct driver for associated markets such as mycoplasma testing. The researches including drug detection and development, receives funding from the governmental bodies to a great extent. Furthermore, governmental initiatives in the form of awareness campaigns for chronic diseases such as cancer are also boosting research-based activities. Thus, the above-mentioned factors are anticipated to grow the market growth.



The global mycoplasma testing market is segmented by product type, technology, application, end-user, and region. The global mycoplasma testing market is segmented by product type into instruments, kits & reagents, services. The global mycoplasma testing market is segmented by technology into ELISA, direct assay, PCR, indirect assay, microbial culture techniques, and enzymatic methods. The global mycoplasma testing market is segmented by application into cell line testing, virus testing, end of production cells testing, and other. The global mycoplasma testing market is segmented by end-user into academic research institutes, cell banks, contract research organizations, pharmaceutical & biotechnology companies, other.The global mycoplasma testing market is segmented by region into North America, Latin America, Europe, Middle East & Africa and Asia Pacific



The increasing demand is anticipated to be driven by growing per-capita disposable incomes and rapid urbanization especially in developing economies of India, China, Indonesia, Brazil, Argentina and Korea among others. The key players in the mycoplasma testing market include Thermo Fisher Scientific Inc., Charles River Laboratories International, Inc., Lonza Group Ltd., Merck KGaA, Roche Diagnostics, SGS S.A., American Type Culture Collection, Bionique Testing Laboratories, Inc., PromoCell GmbH, InvivoGen, Biological Industries Israel Beit Haemek Ltd., WuXiAppTec, NorgenBiotek Corp., Agilent Technologies, Biotools, B & M Labs, S.A, Eurofins Scientific, Gibraltar Laboratories, GeneCopoeia, Inc., GenBio, Hylabs, Minerva Biolabs GmbH, Meridian Bioscience, Inc., Sartorius AG, Savyon Diagnostics, and ScienCell Research Laboratories, Inc. Moreover, they are investing more on E & D activities to strengthen their goodwill in the ever competitive market. The demand is anticipated to increase majorly in the developing regions such as Asia Pacific and Latin America.



The global mycoplasma testing market is segmented



Based on product type

• Instruments

• Kits & reagents

• Services



Based on technology

• Elisa

• Direct assay

• Pcr

• Indirect assay

• Microbial culture techniques

• Enzymatic methods



Based on application

• Cell line testing

• Virus testing

• End of production cells testing

• Other



Based on end user

• Academic research institutes

• Cell banks

• Contract research organizations

• Pharmaceutical & biotechnology companies

• Other



Based on region



• North America

• Latin America

• Europe

• Middle East & Africa

• Asia Pacific



The Leading Key Players in Mycoplasma Testing Market

Thermo Fisher Scientific Inc.
Charles River Laboratories International Inc.
Lonza Group Ltd.
Merck KGaA
Roche Diagnostics
SGS S.A.
American Type Culture Collection
Bionique Testing Laboratories Inc.
PromoCell GmbH
InvivoGen
Biological Industries Israel Beit Haemek Ltd.
WuXiAppTec
NorgenBiotek Corp.
Agilent Technologies
Biotools
B & M Labs
S.A
Eurofins Scientific
Gibraltar Laboratories
GeneCopoeia Inc.
GenBio
Hylabs
Minerva Biolabs GmbH
Meridian Bioscience Inc.
Sartorius AG
Savyon Diagnostics
ScienCell Research Laboratories Inc.